Group B Streptococcus Antigens

Details for Australian Patent Application No. 2010227084 (hide)

Owner ID Biomedical Corporation

Inventors Brodeur, Bernard R.; Rioux, Clement; Boyer, Martine; Charlebois, Isabelle; Hamel, Josee; Martin, Denis

Agent Cullens

Pub. Number AU-B-2010227084

Parent 2007202175

Filing date 11 October 2010

Wipo publication date 4 November 2010

Acceptance publication date 29 March 2012

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

28 October 2010 Complete Application Filed

4 November 2010 Application Open to Public Inspection

  Published as AU-B-2010227084

29 March 2012 Application Accepted

  Published as AU-B-2010227084

26 July 2012 Standard Patent Sealed

16 August 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read ID Biomedical Corporation of Quebec . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

6 September 2012 Assignment Registered

  ID Biomedical Corporation The patent has been assigned to ID Biomedical Corporation of Quebec

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010227085-Air conditioner

2010227083-Seal Cleaning Device